Genomictree Inc.
228760
Rang in Aktien
#19189
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Aktienkurs
$6.56
Marktkapitalisierung
$161.07M
Veränderung (1 Tag)
-0.84%
Veränderung (1 Jahr)
-50.39%
Land
KR
Handel Genomictree Inc. (228760)
Kategorie
Healthcare
Aktien-Split-Historie für Genomictree Inc. (228760)
Die Aktie Genomictree Inc. (Symbol: 228760) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Oct 21, 2026 statt.
Eine 228760-Aktie, die vor dem Oct 21, 2026 gekauft wurde, entspricht heute 0 228760-Aktien.
Der letzte Aktiensplit fand am Oct 21, 2026 statt.
Eine 228760-Aktie, die vor dem Oct 21, 2026 gekauft wurde, entspricht heute 0 228760-Aktien.
Liste der Aktiensplits
| Jahr | Aktien-Split | Multiplikator | Kumulierter Multiplikator |
|---|---|---|---|
| Nicht genügend Daten für die angegebenen Daten. | |||
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
| Unternehmen | Anzahl der Aktiensplits | Kumulierter Multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
